ClinicalTrialsFinder
RecruitingNot ApplicableNCT05855668

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Sponsor

Centre for Addiction and Mental Health

Enrollment

400 participants

Start Date

Nov 10, 2022

Study Type

INTERVENTIONAL

Conditions

Alcohol Use DisorderCannabis Use Disorder

Summary

This 2-arm study will recruit participants with 1) alcohol use disorder and 2) cannabis use disorder for a 12-week cognitive behavioral therapy, following a thorough baseline assessments on executive function, incentive salience, and negative emotionality.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called CBT for people with alcohol use disorder and cannabis use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCBT

12 weeks of group CBT for AUD or CUD

Locations(1)

Centre for Addiction and Mental Health

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05855668

Related Trials

Hepatic Lipid Metabolism-Alcohol Use Disorder

NCT071915611 location

Environment and Alcohol: A Pilot Study

NCT068606071 location

Spironolactone in Alcohol Use Disorder (SAUD)

NCT058071391 location

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

NCT065527411 location

Semaglutide Therapy for Alcohol Reduction (STAR)

NCT060158931 location